P. Syamasundar Rao, MD, FACC

Development of Aortic Coarctation Following Device Closure of Patent Ductus Arteriosus

08/29/2013

This case illustrates the risk for development of coarctation with transcatheter PDA closure, mainly with older devices such as the Gianturco-Grifka Vascular Occlude Device.

This case illustrates the risk...

08/29/2013

Journal of Invasive Cardiology

Commentary

Continued Development of Devices for Transcatheter Closure<br />
of Atrial Septal Defects

08/01/2008

P. Syamasundar Rao , MD, FACC;

Since the description by King,1–3 Rashkind4–6 and their associates of devices to occlude atrial septal defects (ASDs), a number of ASD occluding devices have been designed, investigated and were reviewed elsewhere.7–12 The devices were...

Since the description by...

08/01/2008

Journal of Invasive Cardiology

Severe Aortic Coarctation in Infants Less Than 3 Months: Successful Palliation by Balloon Angioplasty

08/01/2008

Saadeh Jureidini , MD;

P. Syamasundar Rao , MD, FACC;

Ian C. Balfour , MD;

Gautam K. Singh , MD, BDS;

Su-chiung Chen , MD;

Key words: aortic coarctation, balloon angioplasty, infants, neonates, transcatheter management Treatment of native aortic coarctation (AC) by balloon angioplasty (BA) is a controversial issue,1–6 but gradually the procedure is gaining...

Key words: aortic coarctation,...

08/01/2008

Journal of Invasive Cardiology

Commentary

Quest for the Ideal ASD/PFO Closure Device Continues‚Ä¶

03/31/2010

P. Syamasundar Rao , MD, FACC;

Duraisamy Balaguru , MD;

Several devices have been developed over the past four decades for transcatheter occlusion of atrial septal defects (ASD) and patent foramen ovale (PFO) starting with the first reported success in the mid-1970s by King, Mills and their...

Several devices have been...

03/31/2010

Journal of Invasive Cardiology

Commentary

Protein-Losing Enteropathy following the Fontan Operation

08/01/2008

P. Syamasundar Rao , MD, FACC;

Protein-losing enteropathy (PLE) may be defined as excessive loss of proteins across the intestinal mucosa and is due to either a primary gastrointestinal abnormality or secondary to cardiac disease. Initial reports of PLE secondary to...

Protein-losing enteropathy (PLE)...

08/01/2008

Journal of Invasive Cardiology

Commentary

Percutaneous Closure of Patent Ductus Arteriosus ‚Äî Current Status

12/01/2011

P. Syamasundar Rao , MD, FACC;

Since the description of successful surgical ligation of patent ductus arteriosus (PDA) by Gross and Hubbard in 1939,1 surgery has been the procedure of choice in the treatment of PDA. Surgical treatment has been shown to be safe and...

Since the description of...

12/01/2011

Journal of Invasive Cardiology

Commentary

Percutaneous Closure of Patent Ductus Arteriosus: State of the Art

08/01/2008

P. Syamasundar Rao , MD, FACC;

Patent ductus arteriosus (PDA) may be an isolated lesion or may be present in association with other defects. Isolated PDA constitutes 6–11% of all congenital heart defects. The configuration of PDA varies considerably, but most often it has...

Patent ductus arteriosus (PDA)...

08/01/2008

Journal of Invasive Cardiology

Case Report

Severe Intravascular Hemolysis after Transcatheter Coil Occlusion of Patent Ductus Arteriosus

08/01/2008

P. Syamasundar Rao , MD, FACC;

Kamal Gupta , MD;

Since the initial description in late 1960s by Porstmann and associates1,2 of a patent ductus arteriosus (PDA) occluding device, a number of other devices have been studied, as reviewed elsewhere.3,4 Transcatheter closure of PDA using various...

Since the initial description in...

08/01/2008

Journal of Invasive Cardiology

Commentary

Percutaneous Closure of Patent Ductus Arteriosus: State of the Art

08/01/2008

P. Syamasundar Rao , MD, FACC;

NULL

08/01/2008

Journal of Invasive Cardiology